| Screening Protocol for Genetic Diseases of Allergic Inflammation (NCT00852943) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-11-02 |
| Influenza Antiviral DAS181-F03 (NCT01173224) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-11-01 |
| Phase IC Study of Safety and PK of SQ109 300mg Daily (NCT01358162) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-11-01 |
| Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation (NCT01517984) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-11-01 |
| A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines (NCT01172535) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-11-01 |
| Plasmodium Falciparum Clearance Rates in Response to Artesunate in Eastern Cambodia (NCT01240603) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-10-24 |
| Cellular and Humoral Immune Response to Primary and Secondary Immunization With Subvirion H5N1 Vaccines (NCT01086566) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-10-01 |
| Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination (NCT01119521) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-10-01 |
| A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II (NCT01183455) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-10-01 |
| Comparison of Flu Vaccine Doses in Children (NCT01164553) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-10-01 |
| A Research Trial of Aralast in New Onset Diabetes (RETAIN) (NCT01183468) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-10-01 |
| Phase I Study of ETEC Vaccine (NCT01147445) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-09-13 |
| Natural History Study of SCID Disorders (NCT01186913) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-09-02 |
| 2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women (NCT01173211) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-09-01 |
| A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (NCT01116427) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-09-01 |
| Development of Cockroach Immunotherapy by the Inner-City Asthma Consortium (NCT01221285) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-09-01 |
| Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections (NCT01212042) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-09-01 |
| Evaluation of the Safety and Immunogenicity of a Live Attenuated Virus Vaccine for the Prevention of H2N3 Influenza (NCT01175122) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-09-01 |
| ZOSTAVAX® in Renal Transplant Patients (NCT01137669) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-09-01 |
| Associating Renal Transplantation With the ITN Signature of Tolerance (NCT01516177) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-09-01 |
| Evaluating the Safety of ITX 5061 in Treatment-Naive Hepatitis C (HCV)-Infected Adults (NCT01165359) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-09-01 |
| Phase II Tularemia Vaccine Comparison (NCT01150695) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-09-01 |
| Evaluating Heterologous-Insert Prime-Boost HIV Vaccine Regimens in HIV-Uninfected Adults (NCT01095224) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-09-01 |
| Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications (NCT01227967) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-09-01 |
| Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali (NCT01168271) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-08-30 |
| Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders (NCT01212016) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-08-30 |
| EP1300 Polyepitope DNA Vaccine Against Plasmodium Falciparum Malaria (NCT01169077) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-08-01 |
| Live Lung Donor Cross-sectional Cohort Study (NCT01524835) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-08-01 |
| Natural History of Severe Allergic Inflammation and Reactions (NCT01164241) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-07-12 |
| Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7 (NCT00922259) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-07-01 |
| Group Study of the Safety of and Immune Response to a Single Dose of Bird Flu Vaccine (H7N3) in Healthy Adults (NCT00853255) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-07-01 |
| Collection of Blood, Bone Marrow, Leukapheresis, and Tissue Biopsy Samples From Patients and Their Family Members for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases Laboratory Research Studies (NCT01200823) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-07-01 |
| Open Label Study to Evaluate Chronic Hepatitis C Treatment in Latino Subjects With and Without HIV Co-infection (NCT01182298) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-07-01 |
| Evaluation of the Safety and Immune Response of Five Admixtures of a Tetravalent Dengue Virus Vaccine (NCT01072786) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-07-01 |
| Evaluating the Safety and Immune Response of an Adenovirus-Based HIV Vaccine in HIV-Uninfected Adults (NCT01103687) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-07-01 |
| Extended Follow-Up of Participants in Preventive HIV Vaccine Studies in Uganda (NCT01109342) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-07-01 |
| Pilot Study to Estimate the Burden and Distribution of Plasmodium Falciparum Malaria in Kalifabougou, Mali in Preparation for a Prospective Cohort Study of Naturally-Acquired Malaria Immunity (NCT01160562) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-06-23 |
| A Semi-Factorial Cluster-Randomized Trial to Estimate the Effect Size of Community Mobilization and VCT Vans on the Adoption of Voluntary Counseling and Testing (VCT) Services in Andhra Pradesh, India: THE MCVCT STUDY (NCT01160575) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-06-23 |
| Immunogenicity of Off-Schedule Dosing of HPV Vaccine (NCT01030562) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-06-02 |
| Efficacy of Combination Therapies for Gonorrhea Treatment (NCT00926796) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-06-01 |
| EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-immune Adults (NCT01026246) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-06-01 |
| Safety Study of a Human Metapneumovirus Challenge Virus in Healthy Adults (NCT01109329) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-06-01 |
| Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59 (NCT00912496) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-06-01 |
| Safety of a Live Attenuated Human Parainfluenza Virus Type 2 (HPIV2) Vaccine for Adults, Children, and Infants (NCT01139437) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-06-01 |
| Biochemical Response to Interferon-Gamma in Subjects With Specific Gene Mutation in Chronic Granulomatous Disease (NCT01147042) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-05-18 |
| VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older (NCT01132859) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-05-18 |
| Tetravalent Chimeric Dengue Vaccine Trial (NCT01110551) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-05-01 |
| High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals (NCT00885703) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-04-16 |
| A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis (NCT01122914) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-04-14 |
| Blood and Plasma Collection For Use in Future Clinical Trials (NCT01136057) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-04-01 |
| Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkina Faso (NCT01018459) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-04-01 |
| Reslizumab to Prevent Post-treatment Eosinophilia in Loiasis (NCT01111305) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-04-01 |
| Evaluation of the Safety and Immune Response to an Investigational Dengue Type 1 Vaccine (NCT01084291) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-04-01 |
| Cardiovascular Radiologic and Metabolic Assessment in HIV: An Investigation of Pathophysiology (NCT01089114) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-03-08 |
| Safety and Efficacy of Oseltamivir in Children Younger Than One Year of Age (NCT01037634) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-03-01 |
| Empiric Therapy of Mucopurulent Cervicitis (MPC) (NCT01072136) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-03-01 |
| An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re... (NCT01086657) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-02-25 |
| Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children (NCT00802802) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-02-10 |
| Tuberculosis in China (NCT01071603) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-02-02 |
| Safety and Immune Response to an Investigational Dengue Type 2 Vaccine (NCT01073306) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-02-01 |
| Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected Adults (NCT01260727) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-02-01 |
| Evaluating an Ebola and a Marburg Vaccine in Uganda (NCT00997607) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-02-01 |
| Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally (NCT00914732) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-02-01 |
| Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma (NCT00814827) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-01-07 |
| A Phase I Study of Mozobil in the Treatment of Patients With WHIMS (NCT00967785) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-01-06 |
| Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System (NCT01063309) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-01-05 |
| Alloantibodies in Pediatric Heart Transplantation (NCT01005316) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-01-01 |
| Examining the Role of Genetics in Determining the Immune Response to an HIV Vaccine in HIV-Uninfected Adult Twins (NCT01054872) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-01-01 |
| Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects (NCT00991289) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-01-01 |
| Treatment Failure of Chlamydial Infection in Males and Females in Youth Correctional Facilities (NCT00980148) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-12-02 |
| Safety, Tolerability, and Effect of TMC207 and Efavirenz in Healthy Volunteers (NCT00992069) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-12-01 |
| Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers (NCT00880698) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-12-01 |
| Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status (NCT01040091) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-12-01 |
| Safety of and Immune Response to the PENNVAX-B DNA Vaccine With and Without IL-12 in HIV-uninfected Adults (NCT00991354) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-11-01 |
| Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and Children (NCT01021397) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-11-01 |
| Novartis H1N1 Vaccine in Pregnant Women (NCT00992719) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-11-01 |
| H1N1 Vaccine at Two Dose Levels in HIV Positive Adults (NCT00992433) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-11-01 |
| Bone Mineral Density Substudy - An Ancillary Study to MTN-003 (NCT00729573) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-11-01 |
| Safety and Effectiveness of Alendronate for Bone Mineral Density in HIV-infected Children and Adolescents (NCT00921557) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-11-01 |
| Clinical Trial of Idebenone in Primary Progressive Multiple Sclerosis (IPPoMS) (NCT00950248) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-11-01 |
| VRC 309: A Multi-Center, Open-Label, Randomized Phase I Study of an Investigational Influenza DNA Vaccine Followed by 2009/2010 Seasonal Influenza Trivalent Inactivated Vaccine (TIV) Compared to Two Injections of TIV in Adults 45-70 Years (NCT00995982) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-10-08 |
| The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise (NCT01011712) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-10-01 |
| Safety and Efficacy of an H1N1 Influenza Vaccine in People With Asthma (NCT00978120) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-10-01 |
| Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women (NCT00992017) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-10-01 |
| Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth (NCT00992836) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-10-01 |
| Live Kidney Donor Study - Cross-Sectional and Historical Cohort Study (NCT00951977) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-10-01 |
| Vaccine Study for Tick-Borne Encephalitis Virus (TBEV) (NCT01031537) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-09-25 |
| A Pilot Study for Collection of Anti-Influenza A Immune Plasma (NCT00984451) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-09-01 |
| Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations (NCT00963157) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-09-01 |
| Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLE (NCT01702038) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-09-01 |
| Live Kidney Donor Study -Renal Function Study (NCT01158742) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-09-01 |
| H1N1 Vaccine in Pregnant Women (NCT00963430) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-09-01 |
| Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31-7164) in Healthy Adults (NCT00831012) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-09-01 |
| Studies in the Pathogenesis of Systemic Capillary Leak Syndrome (NCT00936325) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-08-24 |
| VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old (NCT00973895) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-08-06 |
| Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations (NCT00943631) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-08-01 |
| Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings (NCT00091936) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-08-01 |
| Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels (NCT00944073) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-08-01 |
| Safety and Effectiveness of TFV 1% Gel, TDF Tablets, and FTC/TDF Tablets in Preventing HIV in Women (NCT00705679) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-08-01 |
| Nontypeable H. Influenzae in Healthy Adults (NCT00905385) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-08-01 |